Council for Innovation Promotion

Publish Date
Government AgendaReports
Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2)

For the United States to maintain its competitive edge on the global stage, we must lead in innovation. This is only achievable...

Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: Second Edition

First released in 2024, the Congressional Innovation Scorecard assesses and rates how the U.S. Congress as a whole — and its individual...

The Patent Eligibility Restoration Act (PERA)
C4IP Patent Myth Video Series
Issue Briefs
Addressing Patent Myths

Activist groups routinely accuse companies of “abusing” the patent system by engaging in practices such as “royalty stacking,” “patent evergreening,” “product hopping,”...

Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Commerce Moves to Take Cut of Research Patents
American Institute of Physics
Counting Patents, Not Progress: Another Misdiagnosis by I-MAK
IPWatchdog
Letters
C4IP Letter to Senate and House IP Subcommittees on Designating October as National IP Month

Dear Chairmen Tillis and Issa and Ranking Members Schiff and Johnson: On behalf of the Council for Innovation Promotion (C4IP), I write...

Council for Innovation Promotion Urges Caution Regarding I-MAK’s New Report on Patents and Drug Pricing

WASHINGTON (October 20, 2025) — Today, the Council for Innovation Promotion (C4IP) Executive Director Frank Cullen released the following statement regarding a...

Inventor Spotlight: Malcom McLean

C4IP is honoring Malcom McLean (1913-2001), whose invention of containerized shipping revolutionized global trade. Born into a farming family in North Carolina,...

Congress should base patent policy on evidence, not accusations
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act....
IAM
News:

News:

Senate Confirms Squires To Lead USPTO,

09/18/2025

Videos:

Videos:

Securing U.S. Innovation: The Role of IP in Advancing Life Sciences,

09/16/2025

Blog:

Blog:

This Month in IP: August 2025,

09/09/2025

Blog:

Blog:

C4IP Coalition Updates: August 2025,

09/09/2025

News:

News:

China pharma deals threaten U.S. biotech,

09/08/2025

C4IP:

C4IP:

Former Trump officials: Strong intellectual property protections are crucial to America’s national security,

08/29/2025

Op-Eds:

Op-Eds:

To Defend Nations, NATO Must Defend Innovation,

08/27/2025

Press Releases:

Press Releases:

Council for Innovation Promotion Urges Congress to Oppose the Medication Affordability and Patent Integrity Act,

08/19/2025

News:

News:

C4IP Urges FTC to Proceed with Caution on Addressing Perceived Drug Pricing Problems,

08/19/2025

Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025

News:

News:

What Attys Want To Know About Lutnick’s Harvard IP Threat,

08/13/2025

News:

News:

Potential impact of US government march-in on Harvard’s patents,

08/12/2025

Scroll to Top